Regeneron Pharmaceuticals Stock Analysis

Regeneron Stock Analysis Notes

About 89.0% of the company shares are owned by institutional investors. The book value of Regeneron Pharmaceuticals was at this time reported as 234.47. The company has Price/Earnings To Growth (PEG) ratio of 1.74. Regeneron Pharmaceuticals recorded earning per share (EPS) of 35.09. The entity had not issued any dividends in recent years. Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company was incorporated in 1988 and is headquartered in Tarrytown, New York. Regeneron Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 10915 people. To find out more about Regeneron Pharmaceuticals contact Leonard Schleifer at 914 847-7000 or learn more at www.regeneron.com.

Regeneron Pharmaceuticals Investment Alerts

Regeneron Pharmaceuticals Upcoming and Recent Events

Regeneron Largest EPS Surprises

View All Earnings Estimates

Regeneron Pharmaceuticals SEC Filings

Regeneron Pharmaceuticals Thematic Classifications

Regeneron Stock Institutional Investors

Note, although Regeneron Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Regeneron Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 88.09 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Regeneron Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Regeneron Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Regeneron Profitablity

The company has Profit Margin (PM) of 0.3 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.36 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.36.

Management Efficiency

Regeneron Pharmaceuticals has return on total asset (ROA) of 0.0921 % which means that it generated a profit of $0.0921 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1722 %, meaning that it created $0.1722 on every $100 dollars invested by stockholders. Regeneron Pharmaceuticals' management efficiency ratios could be used to measure how well Regeneron Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of the 1st of December 2023, Return on Investment is likely to grow to 21.00. Also, Return on Average Assets is likely to grow to 0.17. At this time, Regeneron Pharmaceuticals' Asset Turnover is very stable as compared to the past year. As of the 1st of December 2023, Return on Average Assets is likely to grow to 0.17, while Goodwill and Intangible Assets are likely to drop about 748.8 M.

Technical Drivers

As of the 1st of December, Regeneron Pharmaceuticals holds the Coefficient Of Variation of (2,773), risk adjusted performance of (0.025411), and Variance of 1.02. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Regeneron Pharmaceuticals, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to analyze and collect data for thirteen technical drivers for Regeneron Pharmaceuticals, which can be compared to its competitors. Please check Regeneron Pharmaceuticals standard deviation and value at risk to decide if Regeneron Pharmaceuticals is priced some-what accurately, providing market reflects its current price of 823.72 per share. Given that Regeneron Pharmaceuticals has information ratio of (0.046808), we recommend you to check out Regeneron Pharmaceuticals's recent market performance to make sure the company can sustain itself at a future point.

Regeneron Pharmaceuticals Price Movement Analysis

Regeneron Pharmaceuticals Insider Trading Activities

Regeneron Pharmaceuticals Outstanding Bonds

Regeneron Pharmaceuticals Predictive Daily Indicators

Regeneron Pharmaceuticals Forecast Models

Regeneron Pharmaceuticals' time-series forecasting models are one of many Regeneron Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Regeneron Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Regeneron Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Regeneron shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Regeneron Pharmaceuticals. By using and applying Regeneron Stock analysis, traders can create a robust methodology for identifying Regeneron entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Regeneron analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Regeneron analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Regeneron Pharmaceuticals stock analysis indicators help investors evaluate how Regeneron Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Regeneron Pharmaceuticals shares will generate the highest return on investment. By understating and applying Regeneron Pharmaceuticals stock analysis, traders can identify Regeneron Pharmaceuticals position entry and exit signals to maximize returns.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regeneron Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.Note that the Regeneron Pharmaceuticals information on this page should be used as a complementary analysis to other Regeneron Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

When running Regeneron Pharmaceuticals' price analysis, check to measure Regeneron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regeneron Pharmaceuticals is operating at the current time. Most of Regeneron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Regeneron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regeneron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Regeneron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Is Regeneron Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regeneron Pharmaceuticals. If investors know Regeneron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regeneron Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Regeneron Pharmaceuticals is measured differently than its book value, which is the value of Regeneron that is recorded on the company's balance sheet. Investors also form their own opinion of Regeneron Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Regeneron Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regeneron Pharmaceuticals' market value can be influenced by many factors that don't directly affect Regeneron Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Regeneron Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Regeneron Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regeneron Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.